Financhill
Sell
32

ALCO Quote, Financials, Valuation and Earnings

Last price:
$26.19
Seasonality move :
4%
Day range:
$25.16 - $26.35
52-week range:
$24.14 - $30.75
Dividend yield:
0.77%
P/E ratio:
28.38x
P/S ratio:
4.27x
P/B ratio:
0.79x
Volume:
102.2K
Avg. volume:
37.9K
1-year change:
-10.31%
Market cap:
$199.3M
Revenue:
$46.6M
EPS (TTM):
$0.92
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $92.5M $108.6M $91.9M $39.8M $46.6M
Revenue Growth (YoY) -24.33% 17.36% -15.31% -56.66% 17.06%
 
Cost of Revenues $74.6M $84.7M $106.7M $33.4M $103M
Gross Profit $17.9M $23.9M -$14.8M $6.4M -$56.4M
Gross Profit Margin 19.37% 22.01% -16.06% 16.18% -120.88%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $11M $9.5M $10.1M $10.6M $11.1M
Other Inc / (Exp) $30.3M $35.9M $41.1M $11.5M $81.6M
Operating Expenses $11M $9.5M $10.1M $10.6M $11.1M
Operating Income $6.9M $14.4M -$24.8M -$4.2M -$67.5M
 
Net Interest Expenses $5.9M $4M $3.3M $4.9M $3.2M
EBT. Incl. Unusual Items $31.4M $46.4M $13M $2.5M $11M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $7.7M $11.6M $1.1M $801K $4.6M
Net Income to Company $23.7M $34.8M $11.9M $1.7M $6.4M
 
Minority Interest in Earnings -$52K $39K $573K $177K $618K
Net Income to Common Excl Extra Items $23.7M $34.9M $12.5M $1.8M $7M
 
Basic EPS (Cont. Ops) $3.16 $4.64 $1.65 $0.24 $0.91
Diluted EPS (Cont. Ops) $3.16 $4.64 $1.65 $0.24 $0.91
Weighted Average Basic Share $7.5M $7.6M $7.6M $7.6M $7.6M
Weighted Average Diluted Share $7.5M $7.6M $7.6M $7.6M $7.6M
 
EBITDA $51.6M $65.5M $31.5M $22.9M $29.5M
EBIT $37.4M $50.4M $16.3M $7.4M $14.5M
 
Revenue (Reported) $92.5M $108.6M $91.9M $39.8M $46.6M
Operating Income (Reported) $6.9M $14.4M -$24.8M -$4.2M -$67.5M
Operating Income (Adjusted) $37.4M $50.4M $16.3M $7.4M $14.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $4.9M $4M $1M $680K $935K
Revenue Growth (YoY) 251.01% -17.78% -74.23% -34.05% 37.5%
 
Cost of Revenues $5.4M $4.2M $22.9M -$393K $20.6M
Gross Profit -$532K -$240K -$21.9M $1.1M -$19.7M
Gross Profit Margin -10.94% -6% -2122.79% -- -2105.13%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.7M $2.4M $2.4M $2.5M $3M
Other Inc / (Exp) $27.3M $2.3M $279K $4.1M $39K
Operating Expenses $2.7M $2.4M $2.4M $2.5M $3M
Operating Income -$3.3M -$2.6M -$24.3M -$1.5M -$22.7M
 
Net Interest Expenses $1.3M $779K $678K $1.2M $602K
EBT. Incl. Unusual Items $22.8M -$1.1M -$24.7M $1.4M -$23.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $5.6M -$115K -$3.2M $495K -$5.1M
Net Income to Company $17.2M -$1M -$21.5M $903K -$18.2M
 
Minority Interest in Earnings $42K $35K $393K $37K $35K
Net Income to Common Excl Extra Items $17.2M -$972K -$21.1M $940K -$18.1M
 
Basic EPS (Cont. Ops) $2.30 -$0.13 -$2.79 $0.12 -$2.38
Diluted EPS (Cont. Ops) $2.30 -$0.13 -$2.79 $0.12 -$2.38
Weighted Average Basic Share $7.5M $7.7M $7.6M $7.6M $7.6M
Weighted Average Diluted Share $7.5M $7.7M $7.6M $7.6M $7.6M
 
EBITDA $27.6M $3.5M -$20.2M $6.5M -$18.9M
EBIT $24.2M -$320K -$24M $2.7M -$22.6M
 
Revenue (Reported) $4.9M $4M $1M $680K $935K
Operating Income (Reported) -$3.3M -$2.6M -$24.3M -$1.5M -$22.7M
Operating Income (Adjusted) $24.2M -$320K -$24M $2.7M -$22.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $92.5M $108.6M $91.9M $39.8M $46.6M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $74.6M $84.7M $106.7M $33.4M $103M
Gross Profit $17.9M $23.9M -$14.8M $6.4M -$56.4M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $11M $9.5M $10.1M $10.6M $11.1M
Other Inc / (Exp) $30.3M $35.9M $41.1M $11.5M $81.6M
Operating Expenses $11M $9.5M $10.1M $10.6M $11.1M
Operating Income $6.9M $14.4M -$24.8M -$4.2M -$67.5M
 
Net Interest Expenses $5.9M $4M $3.3M $4.9M $3.2M
EBT. Incl. Unusual Items $31.4M $46.4M $13M $2.5M $11M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $7.7M $11.6M $1.1M $801K $4.6M
Net Income to Company $23.7M $34.8M $11.9M $1.7M $6.4M
 
Minority Interest in Earnings -$52K $39K $573K $177K $618K
Net Income to Common Excl Extra Items $23.7M $34.9M $12.5M $1.8M $7M
 
Basic EPS (Cont. Ops) $3.17 $4.64 $1.65 $0.25 $0.92
Diluted EPS (Cont. Ops) $3.17 $4.64 $1.65 $0.25 $0.92
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $51.6M $65.5M $31.5M $22.9M $29.5M
EBIT $37.4M $50.4M $16.3M $7.4M $14.5M
 
Revenue (Reported) $92.5M $108.6M $91.9M $39.8M $46.6M
Operating Income (Reported) $6.9M $14.4M -$24.8M -$4.2M -$67.5M
Operating Income (Adjusted) $37.4M $50.4M $16.3M $7.4M $14.5M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $108.6M $91.9M $39.8M $46.6M --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $84.7M $106.7M $33.4M $103M --
Gross Profit $23.9M -$14.8M $6.4M -$56.4M --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $9.5M $10.1M $10.6M $11.1M --
Other Inc / (Exp) $35.9M $41.1M $11.5M $81.6M --
Operating Expenses $9.5M $10.1M $10.6M $11.1M --
Operating Income $14.4M -$24.8M -$4.2M -$67.5M --
 
Net Interest Expenses $4M $3.3M $4.9M $3.2M --
EBT. Incl. Unusual Items $46.4M $13M $2.5M $11M --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $11.6M $1.1M $801K $4.6M --
Net Income to Company $34.8M $11.9M $1.7M $6.4M --
 
Minority Interest in Earnings $39K $573K $177K $618K --
Net Income to Common Excl Extra Items $34.9M $12.5M $1.8M $7M --
 
Basic EPS (Cont. Ops) $4.64 $1.65 $0.25 $0.92 --
Diluted EPS (Cont. Ops) $4.64 $1.65 $0.25 $0.92 --
Weighted Average Basic Share $30.2M $30.2M $30.4M $30.5M --
Weighted Average Diluted Share $30.2M $30.3M $30.4M $30.5M --
 
EBITDA $65.5M $31.5M $22.9M $29.5M --
EBIT $50.4M $16.3M $7.4M $14.5M --
 
Revenue (Reported) $108.6M $91.9M $39.8M $46.6M --
Operating Income (Reported) $14.4M -$24.8M -$4.2M -$67.5M --
Operating Income (Adjusted) $50.4M $16.3M $7.4M $14.5M --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $3.2M $886K $865K $1.1M $3.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $4.3M $6.1M $324K $712K $771K
Inventory $40.9M $43.4M $27.7M $52.5M $30.1M
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.4M $1.2M $1.4M $1.7M $1.6M
Total Current Assets $51.9M $54.9M $31.6M $58.8M $40.6M
 
Property Plant And Equipment $350.1M $373.2M $372.5M $361.8M $352.7M
Long-Term Investments -- -- -- -- --
Goodwill $2.2M $2.2M $2.2M $2.2M $2.2M
Other Intangibles -- -- -- -- --
Other Long-Term Assets $19.7M $2.8M $2.9M $5.5M $3.1M
Total Assets $423.9M $433.2M $409.3M $428.4M $398.7M
 
Accounts Payable $3.5M $7.3M $3.4M $6.3M $3.4M
Accrued Expenses $4.4M $4.1M $3.2M $2.8M $3.1M
Current Portion Of Long-Term Debt -- $4.3M $3M $2.6M $1.4M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.4M $875K $1.1M $825K $513K
Total Current Liabilities $21.2M $22.3M $16.5M $15.1M $10.7M
 
Long-Term Debt $140.9M $121M $107.8M $126.1M $90.7M
Capital Leases -- -- -- -- --
Total Liabilities $202.2M $183.1M $160.4M $178M $142.4M
 
Common Stock $8.4M $8.4M $8.4M $8.4M $8.4M
Other Common Equity Adj -- -- -- -- --
Common Equity $216.3M $244.7M $243.7M $245M $251.2M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $5.4M $5.4M $5.1M $5.4M $5.1M
Total Equity $221.8M $250.1M $248.9M $250.4M $256.3M
 
Total Liabilities and Equity $423.9M $433.2M $409.3M $428.4M $398.7M
Cash and Short Terms $3.2M $886K $865K $1.1M $3.2M
Total Debt $150M $125.3M $110.9M $128.7M $92.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $3.2M $886K $865K $1.1M $3.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $4.3M $6.1M $324K $712K $771K
Inventory $40.9M $43.4M $27.7M $52.5M $30.1M
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.4M $1.2M $1.4M $1.7M $1.6M
Total Current Assets $51.9M $54.9M $31.6M $58.8M $40.6M
 
Property Plant And Equipment $350.1M $373.2M $372.5M $361.8M $352.7M
Long-Term Investments -- -- -- -- --
Goodwill $2.2M $2.2M $2.2M $2.2M $2.2M
Other Intangibles -- -- -- -- --
Other Long-Term Assets $19.7M $2.8M $2.9M $5.5M $3.1M
Total Assets $423.9M $433.2M $409.3M $428.4M $398.7M
 
Accounts Payable $3.5M $7.3M $3.4M $6.3M $3.4M
Accrued Expenses $4.4M $4.1M $3.2M $2.8M $3.1M
Current Portion Of Long-Term Debt -- $4.3M $3M $2.6M $1.4M
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities $1.4M $875K $1.1M $825K $513K
Total Current Liabilities $21.2M $22.3M $16.5M $15.1M $10.7M
 
Long-Term Debt $140.9M $121M $107.8M $126.1M $90.7M
Capital Leases -- -- -- -- --
Total Liabilities $202.2M $183.1M $160.4M $178M $142.4M
 
Common Stock $8.4M $8.4M $8.4M $8.4M $8.4M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $5.4M $5.4M $5.1M $5.4M $5.1M
Total Equity $221.8M $250.1M $248.9M $250.4M $256.3M
 
Total Liabilities and Equity $423.9M $433.2M $409.3M $428.4M $398.7M
Cash and Short Terms $3.2M $886K $865K $1.1M $3.2M
Total Debt $150M $125.3M $110.9M $128.7M $92.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $23.7M $34.8M $11.9M $1.7M $6.4M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $1.3M $1.2M $1.2M $935K $719K
Change in Accounts Receivable -$4.4M -$4.2M $7.9M -$472K -$817K
Change in Inventories -$712K -$2.5M -$5.9M -$26.4M -$26.3M
Cash From Operations $1M $16.5M $6.5M -$6.3M -$30.5M
 
Capital Expenditures $22.2M $22.3M $20.7M $16.7M $17.9M
Cash Acquisitions -- -$18.5M -$136K -$77K --
Cash From Investing $9.5M -$3.3M $22.5M -$4.1M $68.2M
 
Dividends Paid (Ex Special Dividend) -$2.5M -$7.1M -$15.1M -$4.9M -$1.5M
Special Dividend Paid
Long-Term Debt Issued $117.5M $47.8M $57.2M $79.3M $36.9M
Long-Term Debt Repaid -$129.8M -$72.7M -$71.8M -$61.6M -$73.8M
Repurchase of Common Stock -$238K -- -- -- --
Other Financing Activities $271K -- $294K $441K $368K
Cash From Financing -$14.7M -$32M -$29M $13.2M -$38M
 
Beginning Cash (CF) $23.8M $19.7M $886K $865K $3.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$4.2M -$18.8M -$21K $2.8M -$294K
Ending Cash (CF) $19.7M $886K $865K $3.7M $3.4M
 
Levered Free Cash Flow -$21.1M -$5.8M -$14.2M -$22.9M -$48.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $17.2M -$1M -$21.5M $903K -$18.2M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $264K $278K $301K $204K $175K
Change in Accounts Receivable -$4.2M -$2.9M $3.2M $3.5M $1.8M
Change in Inventories -$11.6M -$11.8M -$10.3M -$13.6M -$13.6M
Cash From Operations -$20.1M -$17.1M -$4.3M -$5.6M -$11.8M
 
Capital Expenditures $5.2M -$12.2M $5.5M $3.7M $1.6M
Cash Acquisitions -- -- -- -- --
Cash From Investing $23.1M -$4.5M -$5.1M $1.6M -$1.9M
 
Dividends Paid (Ex Special Dividend) -$673K -$3.8M -$3.8M -$380K -$381K
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $7M $147K $10.7M $14.3M $17.6M
Long-Term Debt Repaid -$71.1M -$5.3M -$6.5M -$7.8M -$9.6M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $294K -- -- -- --
Cash From Financing -$64.5M -$8.9M $672K $6.1M $8M
 
Beginning Cash (CF) $81.2M $31.4M $9.5M $1.6M $9.1M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$61.5M -$30.5M -$8.7M $2.1M -$5.7M
Ending Cash (CF) $19.7M $886K $865K $3.7M $3.4M
 
Levered Free Cash Flow -$25.2M -$4.9M -$9.8M -$9.3M -$13.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $23.7M $34.8M $11.9M $1.7M $6.4M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $1.3M $1.2M $1.2M $935K $719K
Change in Accounts Receivable -$4.4M -$4.2M $7.9M -$472K -$817K
Change in Inventories -$712K -$2.5M -$5.9M -$26.4M -$26.3M
Cash From Operations $1M $16.5M $6.5M -$6.3M -$30.5M
 
Capital Expenditures $22.2M $22.3M $20.7M $16.7M $17.9M
Cash Acquisitions -- -- -- -- --
Cash From Investing $9.5M -$3.3M $22.5M -$4.1M $68.2M
 
Dividends Paid (Ex Special Dividend) -$2.5M -$7.1M -$15.1M -$4.9M -$1.5M
Special Dividend Paid
Long-Term Debt Issued $117.5M $47.8M $57.2M $79.3M $36.9M
Long-Term Debt Repaid -$129.8M -$72.7M -$71.8M -$61.6M -$73.8M
Repurchase of Common Stock -$238K -- -- -- --
Other Financing Activities $271K -- -- -- --
Cash From Financing -$14.7M -$32M -$29M $13.2M -$38M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$4.2M -$18.8M -$21K $2.8M -$294K
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$21.1M -$5.8M -$14.2M -$22.9M -$48.4M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $34.8M $11.9M $1.7M $6.4M --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation $1.2M $1.2M $935K $719K --
Change in Accounts Receivable -$4.2M $7.9M -$472K -$817K --
Change in Inventories -$2.5M -$5.9M -$26.4M -$26.3M --
Cash From Operations $16.5M $6.5M -$6.3M -$30.5M --
 
Capital Expenditures $22.3M $20.7M $16.7M $17.9M --
Cash Acquisitions -- -- -- -- --
Cash From Investing -$3.3M $22.5M -$4.1M $68.2M --
 
Dividends Paid (Ex Special Dividend) -$7.1M -$15.1M -$4.9M -$1.5M --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $47.8M $57.2M $79.3M $36.9M --
Long-Term Debt Repaid -$72.7M -$71.8M -$61.6M -$73.8M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- $441K -- --
Cash From Financing -$32M -$29M $13.2M -$38M --
 
Beginning Cash (CF) $64.1M $36.7M $2.9M $40M --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$18.8M -$21K $2.8M -$294K --
Ending Cash (CF) $45.3M $36.6M $5.7M $39.7M --
 
Levered Free Cash Flow -$5.8M -$14.2M -$22.9M -$48.4M --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock